Developer docs
API playgroundTry for free, no card

Search company profiles

Hone Health

Full company profile

uuid00006mt

Namestring
Hone Health
Legal namestring
Hone Health
Websiteurl
honehealth.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Hone Health is a U.S.-based, direct-to-consumer telehealth clinic and longevity care platform founded in 2020 by Saad Alam and headquartered in New York City. The company delivers physician-guided care across men's hormone optimization (TRT, longevity, weight loss, ED, thyroid, hair loss, heart health) and women's perimenopause/menopause (HRT, longevity, weight loss, low libido, thyroid, hair loss, heart health), serving over 350,000 tested patients and 60,000+ treated patients as of August 2025. Its core technology is a custom-built EMR with clinical decision support tools that synthesizes a 50+ biomarker blood panel, validated diagnostic questionnaires (qADAM, MENQOL, PHQ9, RIUS, FSFI), and integrated third-party diagnostics (Prenuvo whole-body MRI, BodySpec DEXA scans) into a single longitudinal care plan.

The platform is accessed via honehealth.com and a patient app, with a $65 entry-point biomarker test offered at 2,000+ CLIA-certified partner lab locations (FSA/HSA eligible, no insurance accepted). Patients convert into one of two membership tiers: Hone Basic at $25/month with semi-annual testing, or Hone Premium at $155/month (chosen by 95% of patients) with quarterly retesting, telehealth physician consults, and personalized protocols. Recurring revenue is layered with prescription medications shipped directly to the patient (e.g., Testosterone from $28/month, Sermorelin $130/month, NAD+ $165/month, Compounded Liraglutide $160/month) and a proprietary women's arousal cream. In-home IV therapy and phlebotomy were added in January 2025 via the acquisition of ivee.

Hone Health closed a $33 million Series A in January 2025 (total capital $39M; investors include Tribe Capital, PIF, Republic Capital, Vibe VC) and has since launched integrated prenatal whole-body MRI (Prenuvo, November 2025), integrated DEXA scans (BodySpec, April 2026), the Hone Heart Health cardiovascular program (June 2026), and the Menopause Time Off (MTO) Movement and Microgrant Fund (May 2026). The company is positioned as the largest men's hormone clinic in the U.S., has 11,709+ Trustpilot reviews, LegitScript certification, and an award-winning editorial platform (The Edge) anchored by a Medical Advisory & Review Board.

Short descriptiontext

Hone Health is a U.S.-based direct-to-consumer telehealth clinic and longevity platform that delivers physician-guided hormone optimization and preventive care to men and women via a $65 entry biomarker test, two membership tiers ($25/mo Basic, $155/mo Premium chosen by 95% of patients), prescription medications, and integrated advanced diagnostics (Prenuvo MRI, BodySpec DEXA), serving 350,000+ tested patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hormone optimization therapy, telehealth longevity care, biomarker blood testing, menopause hormone therapy, testosterone replacement therapy
Industry3 codes
1Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
CodeHLALAFAAPrimaryYes
2Healthy Aging & Longevity Lifestyle Coaching
CodeHSADAGAKPrimaryNo
3Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking)
CodeHLAHACAIPrimaryNo
NAICS code2 codes
  • Offices of Other Health Practitioners6213
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Misc Health & Allied Services, Nec8090
Product category
Telehealth Hormone Optimization & Longevity Care
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Monthly Membership Subscriptions
TypeSubscription Recurring
Description

Recurring monthly memberships via two tiers: Hone Basic ($25/month) for testing every 6 months and member pricing on BASIC medications, and Hone Premium ($155/month) chosen by ~95% of patients, which includes testing every 3 months, physician consults, and full treatment protocols.

honehealth.com
2One-Time Biomarker Test Sales
TypeTransaction Fee
Description

$65 entry-point biomarker test (50+ biomarkers) at 2,000+ partner lab locations, FSA/HSA eligible. Test can be purchased standalone or bundled with a physician consultation as a funnel into membership.

honehealth.com
3Prescription Medication Sales
TypeSubscription Recurring
Description

Recurring revenue from physician-prescribed medications priced per treatment (e.g., Testosterone from $28/mo, Anastrozole $22/mo, Sermorelin $130/mo, NAD+ $165/mo, Compounded Liraglutide $160/mo, Metformin $25/mo, Colchicine $37/mo, Rosuvastatin from $37/mo, Tadalafil from $25/mo) shipped directly to the patient's door plus member-exclusive supplements.

honehealth.com
4Integrated Diagnostic Service Revenue
TypeTransaction Fee
Description

Revenue from integrated advanced diagnostics including Prenuvo whole-body MRI scans and BodySpec DEXA scans booked through the Hone platform, with physician-guided interpretation incorporated into the longitudinal care plan.

honehealth.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels8 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations
Pricing details4 tiers
1Hone Basic membership at $25/month with testing every 6 months
ModelSubscriptionBilling cadenceMonthly
Notes

Includes advanced testing for 50+ key biomarkers every 6 months; ability to purchase telehealth consults; members-only pricing on BASIC medications & supplements. Physician consult available for a nominal fee.

honehealth.com
2Hone Premium membership at $155/month with testing every 3 months
ModelSubscriptionBilling cadenceMonthly
Notes

Chosen by 95% of patients. Includes advanced testing for 50+ key biomarkers, private telehealth consult with licensed physicians, personalized protocols (testosterone, estrogen, weight loss & more), and retesting + follow-ups every 90 days. Plus cost of medication.

honehealth.com
3Initial Biomarker Test + Physician Consult at $65 (one-time)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$65 per biomarker test (50+ biomarkers) at 2,000+ lab locations; FSA/HSA eligible; physician consult included. 100% risk-free entry point.

honehealth.com
4Hone Basic initial test at $25 + $25 onboarding fee
ModelSubscriptionBilling cadenceMonthly
Notes

Lower-cost Basic tier entry with $25 onboarding fee in addition to the $25/month membership. Treatments limited to BASIC labeled medications.

honehealth.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Hone Heart Health
Description

Cardiovascular care program launched in June 2026 designed to identify heart disease risk early using multi-system analysis with a 50+ biomarker blood panel.

prnewswire.com
Core offering1 text field

Hone Health operates a direct-to-consumer telehealth clinic and AI-enabled longevity platform that sells monthly memberships (Hone Basic at $25/month, Hone Premium at $155/month) anchored by a $65 entry-point 50+ biomarker blood test at 2,000+ partner lab locations. Members receive private telehealth consultations with licensed physicians, personalized treatment protocols, prescription medications shipped directly to their door, and access to integrated advanced diagnostics including Prenuvo whole-body MRI and BodySpec DEXA scans for both men (TRT, longevity, weight loss, ED, thyroid, hair loss) and women (menopause HRT, longevity, weight loss, low libido, thyroid, hair loss).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 95% of patients choose Hone Premium ($155/month) membership
+6 more records
Product overview1 text field

Hone Health operates as a unified telehealth and longevity care platform anchored by two membership tiers — Hone Basic ($25/month) and Hone Premium ($155/month) — built around a core Optimal Health Biomarker Test ($65) that analyzes 50+ biomarkers across blood, electrolytes, heart, hormones, immunity, kidneys, liver, metabolic health, and thyroid systems. The platform delivers specialty care modules for men (TRT, longevity, weight loss, ED, thyroid, hair loss, and heart health) and women (menopause HRT, longevity, weight loss, low libido, thyroid, hair loss, and heart health), supported by physician-led telehealth consultations and an in-home healthcare service acquired through ivee. Recent expansions include the Hone Heart Health cardiovascular program, the Menopause Time Off (MTO) Movement, and integrated third-party diagnostics through partnerships with BodySpec (DEXA scans) and Prenuvo (whole-body MRI). All of this is underpinned by The Edge content platform and the company's positioning as an AI-enabled, physician-guided longevity platform serving over 200,000 patients.

Product and service2 records
1Hone Health Telehealth Platform
CategoryCore Telehealth Platform
Description

Online telehealth clinic and AI-enabled personalized longevity care platform for men and women that combines advanced biomarker testing, physician-led consultations, prescription medications, and integrated advanced diagnostics into longitudinal care plans addressing hormones, metabolism, cardiovascular health, thyroid, sexual health, weight, and aging.

2Optimal Health Biomarker Test
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership22 partners
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

Pvolve is named as a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

2Wthn
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

Wthn is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

honehealth.com
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

mywowfit is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

Tone House is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

Womaness is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

Higher Dose is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

Barre 3 is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

Genova Diagnostics is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

Mission Fit is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

10Wishi
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

Wishi is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

honehealth.com
11Nue
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

Nue is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

honehealth.com
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-05-11
Description

Hit House is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.

Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2026-04-14
Description

Hone Health integrated BodySpec's clinical-grade DEXA body composition scans into its personalized longevity care platform in April 2026. The integration provides detailed diagnostics on body fat, muscle mass, bone density, and metabolic health, and shifts preventive bone density screening earlier than the traditional age 65 threshold.

14Ashley Camerini
Strategic tierCoreTypeOthersAnnounced on2026-02-10
Description

Ashley Camerini joined Hone Health as Senior Vice President of Strategic Growth Initiatives in February 2026. Previously CEO of Rumble Boxing (acquired by Xponential Fitness), with senior leadership roles at Barry's and investment banking roles at Jefferies and L Catterton. Role is newly created to scale new growth opportunities, forge strategic partnerships, and expand reach in the longevity care sector.

prnewswire.com
Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2025-11-06
Description

Hone Health integrated Prenuvo's whole-body MRI scans into its longevity care platform in November 2025. Patients can book Prenuvo scans through the Hone Health app, receive detailed radiologist-reviewed reports, and work with Hone clinicians on personalized treatment plans. Prenuvo has completed over 150,000 scans; 1 in 20 detects a potentially life-saving diagnosis.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-28
Description

Hone Health acquired ivee in January 2025 alongside its $33M Series A funding. ivee is an at-home healthcare services platform offering at-home IV therapy and phlebotomy. The acquisition extends Hone's offerings into in-home healthcare services as part of its longevity care expansion.

Strategic tierFlagshipTypeImplementation/ SI/ Consulting Partner
Description

Broad Health is the affiliated medical practice through which Hone works to find physicians. Through this partnership, Hone is building a network of hormone optimization, preventative, and regenerative physicians. The independent, physician-owned medical group is responsible for all decisions related to physicians and medical care.

18Paul Wesley
Strategic tierCoreTypeGTM or Marketing Partner
Description

Actor, entrepreneur, and investor Paul Wesley serves as a Hone Health brand ambassador, featured prominently on the homepage with a personal quote about partnering with Hone on the longevity pursuit.

honehealth.com
19Nikki and Brie Garcia
Strategic tierCoreTypeGTM or Marketing Partner
Description

Athletes, podcast hosts and mothers Nikki and Brie Garcia serve as Hone Health brand ambassadors, featured on the homepage sharing their experience using Hone's biomarker testing.

honehealth.com
20Dan Churchill
Strategic tierCoreTypeGTM or Marketing Partner
Description

Chef, hybrid athlete, and entrepreneur Dan Churchill serves as a Hone Health brand ambassador, sharing how Hone helped him understand his endocrine system.

honehealth.com
Strategic tierCoreTypeGTM or Marketing Partner
Description

Neurophysiologist, podcast host, and scientist Louisa Nicola serves as a Hone Health brand ambassador, featured for her testosterone optimization success (11 to 25 ng/dL after 3 months on Hone).

22Brendan Fallis
Strategic tierCoreTypeGTM or Marketing Partner
Description

International DJ, entrepreneur, and father Brendan Fallis serves as a Hone Health brand ambassador, featured in a dedicated Edge article 'Brendan Fallis Turned Data into Power.'

honehealth.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Public D2C telehealth company offering men's and women's health treatments (TRT, ED, hair loss, weight loss, mental health) via subscription. Most directly comparable to Hone in business model, customer base, and category.

2Ro
TypeDirect peer
Description

D2C telehealth platform spanning men's health (Roman), women's health, weight loss (Ro Body), and diagnostics. Direct competitor in men's hormone care with a similarly integrated vertical model.

TypeDirect peer
Description

Membership-based preventive health platform offering 100+ biomarker testing and physician-led interpretation, targeting the same 'longevity' consumer and competing head-to-head for the same demographic as Hone.

TypeDirect peer
Description

Blood-based biomarker analysis with personalized healthspan/longevity recommendations. Comparable to Hone's 50+ biomarker test + protocol offering, though without the in-house physician prescribing layer.

TypeDirect peer
Description

Telehealth clinic focused on perimenopause and menopause care for women, with insurance coverage. Direct competitor to Hone's women's menopause and HRT offering.

TypeBroad incumbent
Description

Larger virtual care provider for women and families, with strong employer channel. Overlaps with Hone's women's health and menopause modules, but its core is maternity/fertility rather than hormone optimization.

TypeEmerging player
Description

Telehealth provider focused exclusively on perimenopause and menopause care for women. Narrower than Hone's women's offering but directly competes for the same patient demographic.

TypeDirect peer
Description

Telehealth weight loss program combining GLP-1 medications with coaching. Comparable in structure to Hone's weight loss program (Sermorelin, Liraglutide, Phentermine) and shares the D2C subscription model.

TypeEmerging player
Description

At-home diagnostics and telehealth platform offering direct-to-consumer lab tests and physician follow-up. Adjacent competitor in the D2C testing and integrated care space.

TypeEmerging player
Description

Continuous glucose monitor and metabolic-health program focused on optimizing energy and body composition. Competes for the same healthspan/longevity-oriented customer segment as Hone.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers16 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hone Health

Telehealth Hormone Optimization & Longevity Carehonehealth.com

Hone Health is a U.S.-based direct-to-consumer telehealth clinic and longevity platform that delivers physician-guided hormone optimization and preventive care to men and women via a $65 entry biomarker test, two membership tiers ($25/mo Basic, $155/mo Premium chosen by 95% of patients), prescription medications, and integrated advanced diagnostics (Prenuvo MRI, BodySpec DEXA), serving 350,000+ tested patients.

What Hone Health does

Hone Health is a U.S.-based, direct-to-consumer telehealth clinic and longevity care platform founded in 2020 by Saad Alam and headquartered in New York City. The company delivers physician-guided care across men's hormone optimization (TRT, longevity, weight loss, ED, thyroid, hair loss, heart health) and women's perimenopause/menopause (HRT, longevity, weight loss, low libido, thyroid, hair loss, heart health), serving over 350,000 tested patients and 60,000+ treated patients as of August 2025. Its core technology is a custom-built EMR with clinical decision support tools that synthesizes a 50+ biomarker blood panel, validated diagnostic questionnaires (qADAM, MENQOL, PHQ9, RIUS, FSFI), and integrated third-party diagnostics (Prenuvo whole-body MRI, BodySpec DEXA scans) into a single longitudinal care plan.

The platform is accessed via honehealth.com and a patient app, with a $65 entry-point biomarker test offered at 2,000+ CLIA-certified partner lab locations (FSA/HSA eligible, no insurance accepted). Patients convert into one of two membership tiers: Hone Basic at $25/month with semi-annual testing, or Hone Premium at $155/month (chosen by 95% of patients) with quarterly retesting, telehealth physician consults, and personalized protocols. Recurring revenue is layered with prescription medications shipped directly to the patient (e.g., Testosterone from $28/month, Sermorelin $130/month, NAD+ $165/month, Compounded Liraglutide $160/month) and a proprietary women's arousal cream. In-home IV therapy and phlebotomy were added in January 2025 via the acquisition of ivee.

Hone Health closed a $33 million Series A in January 2025 (total capital $39M; investors include Tribe Capital, PIF, Republic Capital, Vibe VC) and has since launched integrated prenatal whole-body MRI (Prenuvo, November 2025), integrated DEXA scans (BodySpec, April 2026), the Hone Heart Health cardiovascular program (June 2026), and the Menopause Time Off (MTO) Movement and Microgrant Fund (May 2026). The company is positioned as the largest men's hormone clinic in the U.S., has 11,709+ Trustpilot reviews, LegitScript certification, and an award-winning editorial platform (The Edge) anchored by a Medical Advisory & Review Board.

Hone Health firmographics

Firmographics
Name
Hone Health
Legal name
Hone Health
Website
https://honehealth.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Hone Health is a U.S.-based direct-to-consumer telehealth clinic and longevity platform that delivers physician-guided hormone optimization and preventive care to men and women via a $65 entry biomarker test, two membership tiers ($25/mo Basic, $155/mo Premium chosen by 95% of patients), prescription medications, and integrated advanced diagnostics (Prenuvo MRI, BodySpec DEXA), serving 350,000+ tested patients.
Ownership category
akta.pro rank

Hone Health industry classification

Industry
Product category
Telehealth Hormone Optimization & Longevity Care
NAICS
Offices of Other Health Practitioners (6213), Medical and Diagnostic Laboratories (6215)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
akta.pro secondary industries
Healthy Aging & Longevity Lifestyle Coaching (HSADAGAK), Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking) (HLAHACAI)

Keywords

  • Hormone optimization therapy
  • Telehealth longevity care
  • Biomarker blood testing
  • Menopause hormone therapy
  • Testosterone replacement therapy

Where Hone Health is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Hone Health business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations

Revenue model

  1. Monthly Membership Subscriptions: Recurring monthly memberships via two tiers: Hone Basic ($25/month) for testing every 6 months and member pricing on BASIC medications, and Hone Premium ($155/month) chosen by ~95% of patients, which includes testing every 3 months, physician consults, and full treatment protocols.
  2. One-Time Biomarker Test Sales: $65 entry-point biomarker test (50+ biomarkers) at 2,000+ partner lab locations, FSA/HSA eligible. Test can be purchased standalone or bundled with a physician consultation as a funnel into membership.
  3. Prescription Medication Sales: Recurring revenue from physician-prescribed medications priced per treatment (e.g., Testosterone from $28/mo, Anastrozole $22/mo, Sermorelin $130/mo, NAD+ $165/mo, Compounded Liraglutide $160/mo, Metformin $25/mo, Colchicine $37/mo, Rosuvastatin from $37/mo, Tadalafil from $25/mo) shipped directly to the patient's door plus member-exclusive supplements.
  4. Integrated Diagnostic Service Revenue: Revenue from integrated advanced diagnostics including Prenuvo whole-body MRI scans and BodySpec DEXA scans booked through the Hone platform, with physician-guided interpretation incorporated into the longitudinal care plan.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyHone Basic membership at $25/month with testing every 6 months
SubscriptionMonthlyHone Premium membership at $155/month with testing every 3 months
Unit PricingPay-as-you-goInitial Biomarker Test + Physician Consult at $65 (one-time)
SubscriptionMonthlyHone Basic initial test at $25 + $25 onboarding fee

Go-to-market motion1 record

Distribution channels8 records

Marketing channels10 records

Hone Health product offering

Product offering

Core offering

Hone Health operates a direct-to-consumer telehealth clinic and AI-enabled longevity platform that sells monthly memberships (Hone Basic at $25/month, Hone Premium at $155/month) anchored by a $65 entry-point 50+ biomarker blood test at 2,000+ partner lab locations. Members receive private telehealth consultations with licensed physicians, personalized treatment protocols, prescription medications shipped directly to their door, and access to integrated advanced diagnostics including Prenuvo whole-body MRI and BodySpec DEXA scans for both men (TRT, longevity, weight loss, ED, thyroid, hair loss) and women (menopause HRT, longevity, weight loss, low libido, thyroid, hair loss).

Product overview

Hone Health operates as a unified telehealth and longevity care platform anchored by two membership tiers — Hone Basic ($25/month) and Hone Premium ($155/month) — built around a core Optimal Health Biomarker Test ($65) that analyzes 50+ biomarkers across blood, electrolytes, heart, hormones, immunity, kidneys, liver, metabolic health, and thyroid systems. The platform delivers specialty care modules for men (TRT, longevity, weight loss, ED, thyroid, hair loss, and heart health) and women (menopause HRT, longevity, weight loss, low libido, thyroid, hair loss, and heart health), supported by physician-led telehealth consultations and an in-home healthcare service acquired through ivee. Recent expansions include the Hone Heart Health cardiovascular program, the Menopause Time Off (MTO) Movement, and integrated third-party diagnostics through partnerships with BodySpec (DEXA scans) and Prenuvo (whole-body MRI). All of this is underpinned by The Edge content platform and the company's positioning as an AI-enabled, physician-guided longevity platform serving over 200,000 patients.

Differentiator

Problem solved

Functional benefit

Brands

  • Hone Heart Health: Cardiovascular care program launched in June 2026 designed to identify heart disease risk early using multi-system analysis with a 50+ biomarker blood panel.

Products and services

  • Hone Health Telehealth Platform Online telehealth clinic and AI-enabled personalized longevity care platform for men and women that combines advanced biomarker testing, physician-led consultations, prescription medications, and integrated advanced diagnostics into longitudinal care plans addressing hormones, metabolism, cardiovascular health, thyroid, sexual health, weight, and aging.
  • Optimal Health Biomarker Test

Quantifiable outcome

  • 95% of patients choose Hone Premium ($155/month) membership
  • +6 more outcomes

Companies that use Hone Health

Customer profile

Named customers16 records

Segments4 records

Ideal customer profiles4 records

Hone Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature6 records

Hone Health partnerships and signals

Strategic signal

Partnerships

22 partnerships are on record, tiered minor, flagship and core.

  • PvolveminorGTM or Marketing Partner · 11 May 2026Pvolve is named as a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • WthnminorGTM or Marketing Partner · 11 May 2026Wthn is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • mywowfitminorGTM or Marketing Partner · 11 May 2026mywowfit is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • Tone HouseminorGTM or Marketing Partner · 11 May 2026Tone House is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • WomanessminorGTM or Marketing Partner · 11 May 2026Womaness is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • Higher DoseminorGTM or Marketing Partner · 11 May 2026Higher Dose is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • Barre 3minorGTM or Marketing Partner · 11 May 2026Barre 3 is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • Genova DiagnosticsminorGTM or Marketing Partner · 11 May 2026Genova Diagnostics is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • Mission FitminorGTM or Marketing Partner · 11 May 2026Mission Fit is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • WishiminorGTM or Marketing Partner · 11 May 2026Wishi is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • NueminorGTM or Marketing Partner · 11 May 2026Nue is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • Hit HouseminorGTM or Marketing Partner · 11 May 2026Hit House is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
  • BodySpecflagshipTechnology or Integration · 14 April 2026Hone Health integrated BodySpec's clinical-grade DEXA body composition scans into its personalized longevity care platform in April 2026. The integration provides detailed diagnostics on body fat, muscle mass, bone density, and metabolic health, and shifts preventive bone density screening earlier than the traditional age 65 threshold.
  • Ashley CamerinicoreOthers · 10 February 2026Ashley Camerini joined Hone Health as Senior Vice President of Strategic Growth Initiatives in February 2026. Previously CEO of Rumble Boxing (acquired by Xponential Fitness), with senior leadership roles at Barry's and investment banking roles at Jefferies and L Catterton. Role is newly created to scale new growth opportunities, forge strategic partnerships, and expand reach in the longevity care sector.
  • PrenuvoflagshipTechnology or Integration · 6 November 2025Hone Health integrated Prenuvo's whole-body MRI scans into its longevity care platform in November 2025. Patients can book Prenuvo scans through the Hone Health app, receive detailed radiologist-reviewed reports, and work with Hone clinicians on personalized treatment plans. Prenuvo has completed over 150,000 scans; 1 in 20 detects a potentially life-saving diagnosis.
  • iveecoreStrategic or Co-development Partner · 28 January 2025Hone Health acquired ivee in January 2025 alongside its $33M Series A funding. ivee is an at-home healthcare services platform offering at-home IV therapy and phlebotomy. The acquisition extends Hone's offerings into in-home healthcare services as part of its longevity care expansion.
  • Broad HealthflagshipImplementation/ SI/ Consulting PartnerBroad Health is the affiliated medical practice through which Hone works to find physicians. Through this partnership, Hone is building a network of hormone optimization, preventative, and regenerative physicians. The independent, physician-owned medical group is responsible for all decisions related to physicians and medical care.
  • Paul WesleycoreGTM or Marketing PartnerActor, entrepreneur, and investor Paul Wesley serves as a Hone Health brand ambassador, featured prominently on the homepage with a personal quote about partnering with Hone on the longevity pursuit.
  • Nikki and Brie GarciacoreGTM or Marketing PartnerAthletes, podcast hosts and mothers Nikki and Brie Garcia serve as Hone Health brand ambassadors, featured on the homepage sharing their experience using Hone's biomarker testing.
  • Dan ChurchillcoreGTM or Marketing PartnerChef, hybrid athlete, and entrepreneur Dan Churchill serves as a Hone Health brand ambassador, sharing how Hone helped him understand his endocrine system.
  • Louisa NicolacoreGTM or Marketing PartnerNeurophysiologist, podcast host, and scientist Louisa Nicola serves as a Hone Health brand ambassador, featured for her testosterone optimization success (11 to 25 ng/dL after 3 months on Hone).
  • Brendan FalliscoreGTM or Marketing PartnerInternational DJ, entrepreneur, and father Brendan Fallis serves as a Hone Health brand ambassador, featured in a dedicated Edge article 'Brendan Fallis Turned Data into Power.'

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Hone Health competitors and assessment

Company assessment

Direct peers

  • Hims & Hers Health: Public D2C telehealth company offering men's and women's health treatments (TRT, ED, hair loss, weight loss, mental health) via subscription. Most directly comparable to Hone in business model, customer base, and category.
  • Ro: D2C telehealth platform spanning men's health (Roman), women's health, weight loss (Ro Body), and diagnostics. Direct competitor in men's hormone care with a similarly integrated vertical model.
  • Function Health: Membership-based preventive health platform offering 100+ biomarker testing and physician-led interpretation, targeting the same 'longevity' consumer and competing head-to-head for the same demographic as Hone.
  • InsideTracker: Blood-based biomarker analysis with personalized healthspan/longevity recommendations. Comparable to Hone's 50+ biomarker test + protocol offering, though without the in-house physician prescribing layer.
  • Midi Health: Telehealth clinic focused on perimenopause and menopause care for women, with insurance coverage. Direct competitor to Hone's women's menopause and HRT offering.
  • Calibrate: Telehealth weight loss program combining GLP-1 medications with coaching. Comparable in structure to Hone's weight loss program (Sermorelin, Liraglutide, Phentermine) and shares the D2C subscription model.

Broad incumbents

  • Maven Clinic: Larger virtual care provider for women and families, with strong employer channel. Overlaps with Hone's women's health and menopause modules, but its core is maternity/fertility rather than hormone optimization.

Emerging players

  • Evernow: Telehealth provider focused exclusively on perimenopause and menopause care for women. Narrower than Hone's women's offering but directly competes for the same patient demographic.
  • LetsGetChecked: At-home diagnostics and telehealth platform offering direct-to-consumer lab tests and physician follow-up. Adjacent competitor in the D2C testing and integrated care space.
  • Veri: Continuous glucose monitor and metabolic-health program focused on optimizing energy and body composition. Competes for the same healthspan/longevity-oriented customer segment as Hone.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Hone Health social profiles

Digital presence

Hone Health compliance and trust

Trust signal

Compliance3 records

Hone Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hone Health leadership team

Management profile

Number of profiles

Profiles9 records

Hone Health subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Hone Health funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hone Health M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hone Health

What does Hone Health do?

Hone Health operates a direct-to-consumer telehealth clinic and AI-enabled longevity platform that sells monthly memberships (Hone Basic at $25/month, Hone Premium at $155/month) anchored by a $65 entry-point 50+ biomarker blood test at 2,000+ partner lab locations. Members receive private telehealth consultations with licensed physicians, personalized treatment protocols, prescription medications shipped directly to their door, and access to integrated advanced diagnostics including Prenuvo whole-body MRI and BodySpec DEXA scans for both men (TRT, longevity, weight loss, ED, thyroid, hair loss) and women (menopause HRT, longevity, weight loss, low libido, thyroid, hair loss).

Is Hone Health a public or private company?

Hone Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Hone Health founded?

Hone Health was founded in 2020. It employs 11 to 50 people.

Where is Hone Health based?

Hone Health is headquartered in New York, United States, in the North America region.

How does Hone Health make money?

Four revenue lines are on record. Monthly Membership Subscriptions are the primary driver. The others are one-Time Biomarker Test Sales, prescription Medication Sales and integrated Diagnostic Service Revenue.

Who are Hone Health's main competitors?

Direct peers on record are Hims & Hers Health, Ro, Function Health, InsideTracker, Midi Health and Calibrate. Maven Clinic is listed as a broad incumbent. Emerging players are Evernow, LetsGetChecked and Veri.

Does Hone Health have an API?

No public API is recorded for Hone Health.

What industry is Hone Health in?

Hone Health's product category is Telehealth Hormone Optimization & Longevity Care. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of HSADAGAK, Healthy Aging & Longevity Lifestyle Coaching. Its NAICS code is 6213 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AthletechnewsBodybar Pilates Adds Longevity Care Through Hone Health PartnershipBodybar Pilates partnered with longevity platform Hone Health to offer members biomarker testing and physician-guided care at over 40 studios across seven U.S. states. Members receive 20% off Hone testing and a year of Hone Premium, while Hone members get 15% off Bodybar memberships. The deal extends beyond the studio, as fitness operators increasingly connect workouts with health diagnostics.TrendHunter.comIntegrated Longevity-Focused PartnershipsHone Health and WTHN announced a partnership combining biomarker-driven care with Traditional Chinese Medicine. The collaboration includes exclusive member discounts, an educational guide on stress and aging, and a live panel event on July 22, 2026, in New York City.FittHone Health and WTHN Announce Longevity PartnershipHone Health and WTHN announced a strategic partnership to integrate biomarker-driven clinical care with Traditional Chinese Medicine for longevity management. The collaboration includes exclusive member offers, an educational guide on stress and aging, and a joint panel event scheduled for July 22, 2026, in New York City.PR NewswireHone Health and WTHN Announce Longevity PartnershipHone Health and WTHN have announced a new partnership to offer integrated longevity and wellness services, combining Hone's biomarker-driven, physician-guided approach to hormones and metabolism with WTHN's science-backed Traditional Chinese Medicine treatments including acupuncture and cupping. The partnership includes exclusive member discounts across both brands, a downloadable educational guide on stress and aging, and a live panel event scheduled for July 22, 2026 in New York City. The collaboration reflects a growing industry trend toward combining Eastern and Western medical approaches to address interconnected health factors like stress, sleep, hormones, and recovery as part of a whole-body longevity practice.MorningstarHone Health and WTHN Announce Longevity PartnershipHone Health and WTHN announced a longevity partnership on July 22, 2026, combining biomarker-driven care with Traditional Chinese Medicine. The partnership includes exclusive member offers, a stress-and-aging guide, and a live panel event in New York City. The event will feature speakers from both brands discussing integrated longevity approaches.PR NewswireHone Health Launches a New Cardiovascular Care Program to Detect Heart Risk EarlierHone Health, a personalized medical platform focused on longevity, announced the launch of Hone Heart Health, a cardiovascular program designed to identify heart disease risk early using multi-system analysis beyond standard cholesterol testing. The $65 blood panel measures 50+ biomarkers to analyze how arterial inflammation, metabolic dysfunction, liver stress, and hormone decline interact to drive cardiovascular risk. The program is available immediately to new and existing patients, representing Hone's latest expansion into complex multi-system disease management on a platform that has served over 200,000 patients.PR NewswireHone Health Launches the Menopause Time Off (MTO) Movement and FundHone Health, a personalized longevity care clinic, has launched the Menopause Time Off (MTO) Movement during Women's Health Month to address the lack of workplace support for women managing menopause symptoms during their peak earning and leadership years.MedCity NewsBeyond the Scale: How Imaging Can Help Determine GLP-1 EfficacyHone Health partnered with BodySpec to offer DEXA body composition scans to patients taking GLP-1 medications, aiming to measure fat loss and muscle preservation beyond weight. The scans are available via Hone's app or at BodySpec's 12 metro-area locations and mobile vans. The initiative reflects a shift toward body composition metrics as GLP-1 use scales.Longevity.TechnologyHone Health adds DEXA scans to personalized longevity platformHone Health integrated BodySpec's clinical-grade DEXA scans into its longevity platform, enabling physicians to assess body composition, visceral fat, and bone density. The partnership aims to provide earlier, more accurate health insights by combining scan data with hormone and metabolic markers. The integration follows Hone's earlier partnership with Prenuvo for whole-body MRI scans.BeautymatterHow Menopause and Longevity Are Reshaping the IndustryThe global menopause market, valued at $18 billion in 2024 and projected to reach $27 billion by 2030, represents a $131 billion opportunity in the US as the industry reframes menopause from a crisis narrative to a longevity inflection point. Beauty brands, biotech startups, and telehealth companies including L'Oréal, OneSkin, Mira, Modern Age Skin, Hone Health, and Alloy are developing science-backed, personalized solutions targeting the 1.2 billion women expected to be menopausal or post-menopausal globally by 2030. Industry leaders are operationalizing healthspan prioritization through biotech actives, closed-loop diagnostics, subscription protocols, and retail-as-healthspan-hub models, backed by $8.5 billion in longevity investment—a 220% increase from 2023 to 2024.